The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness

Objective: The use of corticosteroid in Kawasaki disease (KD) remains controversial among current guidelines. The objective of this study is to summarize the effectiveness and safety of corticosteroid to prevent coronary arterial lesions in Kawasaki disease, both as initial and rescue therapy. Metho...

Full description

Bibliographic Details
Main Authors: Tsung-Ju Yang, Ming-Tai Lin, Chun-Yi Lu, Jong-Min Chen, Ping-Ing Lee, Li-Min Huang, Mei-Hwan Wu, Luan-Yin Chang
Format: Article
Language:English
Published: Elsevier 2018-06-01
Series:Journal of Microbiology, Immunology and Infection
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1684118217301950
_version_ 1811331675756429312
author Tsung-Ju Yang
Ming-Tai Lin
Chun-Yi Lu
Jong-Min Chen
Ping-Ing Lee
Li-Min Huang
Mei-Hwan Wu
Luan-Yin Chang
author_facet Tsung-Ju Yang
Ming-Tai Lin
Chun-Yi Lu
Jong-Min Chen
Ping-Ing Lee
Li-Min Huang
Mei-Hwan Wu
Luan-Yin Chang
author_sort Tsung-Ju Yang
collection DOAJ
description Objective: The use of corticosteroid in Kawasaki disease (KD) remains controversial among current guidelines. The objective of this study is to summarize the effectiveness and safety of corticosteroid to prevent coronary arterial lesions in Kawasaki disease, both as initial and rescue therapy. Methods: The Medline, EMBASE, Google scholar, Cochrane Central Register of Controlled Trials databases, ClinicalTrials.gov, and Japanese Institutional Repositories Online were searched for studies up to 31 March 2017. Studies that compared incidence of coronary artery lesions between regimens with corticosteroid and regimen without it in a well-defined controlled group were included. The incidence of coronary artery lesion was analyzed by meta-analysis. Results: Nineteen studies published between 1999 and 2016 fulfilled eligibility criteria. There were 3591 patients included for analysis. There was a significant reduction in incidence of coronary artery lesions with usage of corticosteroid with a pooled odds ratio of 0.72 (95% CI 0.57–0.92; p = 0.01) than that without usage of corticosteroid. In general, a greater effect was seen in the patient received corticosteroid as initial and adjuvant therapy with intravenous immune globulin (pooled odds ratio 0.39, 95% CI 0.21–0.73, p = 0.007) than those who received corticosteroid as rescue therapy. The risk reduction was statistically significant in Japanese groups (OR 0.56, 95% CI 0.42–0.75 in fixed effects model) but not significant in non-Japanese groups (OR 1.45, 95% CI 0.91–2.30 in fixed effects model). Conclusions: We demonstrated an overall reduction in incidence of coronary artery lesions with the use of corticosteroid as initial and adjuvant treatment for Kawasaki disease.
first_indexed 2024-04-13T16:24:14Z
format Article
id doaj.art-dc166585fff540b68ffc17d5dc77fbcc
institution Directory Open Access Journal
issn 1684-1182
language English
last_indexed 2024-04-13T16:24:14Z
publishDate 2018-06-01
publisher Elsevier
record_format Article
series Journal of Microbiology, Immunology and Infection
spelling doaj.art-dc166585fff540b68ffc17d5dc77fbcc2022-12-22T02:39:47ZengElsevierJournal of Microbiology, Immunology and Infection1684-11822018-06-0151332133110.1016/j.jmii.2017.08.012The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectivenessTsung-Ju YangMing-Tai LinChun-Yi LuJong-Min ChenPing-Ing LeeLi-Min HuangMei-Hwan WuLuan-Yin ChangObjective: The use of corticosteroid in Kawasaki disease (KD) remains controversial among current guidelines. The objective of this study is to summarize the effectiveness and safety of corticosteroid to prevent coronary arterial lesions in Kawasaki disease, both as initial and rescue therapy. Methods: The Medline, EMBASE, Google scholar, Cochrane Central Register of Controlled Trials databases, ClinicalTrials.gov, and Japanese Institutional Repositories Online were searched for studies up to 31 March 2017. Studies that compared incidence of coronary artery lesions between regimens with corticosteroid and regimen without it in a well-defined controlled group were included. The incidence of coronary artery lesion was analyzed by meta-analysis. Results: Nineteen studies published between 1999 and 2016 fulfilled eligibility criteria. There were 3591 patients included for analysis. There was a significant reduction in incidence of coronary artery lesions with usage of corticosteroid with a pooled odds ratio of 0.72 (95% CI 0.57–0.92; p = 0.01) than that without usage of corticosteroid. In general, a greater effect was seen in the patient received corticosteroid as initial and adjuvant therapy with intravenous immune globulin (pooled odds ratio 0.39, 95% CI 0.21–0.73, p = 0.007) than those who received corticosteroid as rescue therapy. The risk reduction was statistically significant in Japanese groups (OR 0.56, 95% CI 0.42–0.75 in fixed effects model) but not significant in non-Japanese groups (OR 1.45, 95% CI 0.91–2.30 in fixed effects model). Conclusions: We demonstrated an overall reduction in incidence of coronary artery lesions with the use of corticosteroid as initial and adjuvant treatment for Kawasaki disease.http://www.sciencedirect.com/science/article/pii/S1684118217301950Kawasaki diseaseCorticosteroidCoronary artery aneurysmsCoronary artery lesionsAcquired heart disease in children
spellingShingle Tsung-Ju Yang
Ming-Tai Lin
Chun-Yi Lu
Jong-Min Chen
Ping-Ing Lee
Li-Min Huang
Mei-Hwan Wu
Luan-Yin Chang
The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness
Journal of Microbiology, Immunology and Infection
Kawasaki disease
Corticosteroid
Coronary artery aneurysms
Coronary artery lesions
Acquired heart disease in children
title The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness
title_full The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness
title_fullStr The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness
title_full_unstemmed The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness
title_short The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness
title_sort prevention of coronary arterial abnormalities in kawasaki disease a meta analysis of the corticosteroid effectiveness
topic Kawasaki disease
Corticosteroid
Coronary artery aneurysms
Coronary artery lesions
Acquired heart disease in children
url http://www.sciencedirect.com/science/article/pii/S1684118217301950
work_keys_str_mv AT tsungjuyang thepreventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness
AT mingtailin thepreventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness
AT chunyilu thepreventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness
AT jongminchen thepreventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness
AT pinginglee thepreventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness
AT liminhuang thepreventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness
AT meihwanwu thepreventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness
AT luanyinchang thepreventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness
AT tsungjuyang preventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness
AT mingtailin preventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness
AT chunyilu preventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness
AT jongminchen preventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness
AT pinginglee preventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness
AT liminhuang preventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness
AT meihwanwu preventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness
AT luanyinchang preventionofcoronaryarterialabnormalitiesinkawasakidiseaseametaanalysisofthecorticosteroideffectiveness